‘Substantive evidence’ on HCV cure benefits

Direct-acting antivirals are associated with reduced risk of mortality and liver cancer, according to results from the first prospective, longitudinal study investigating their use in treating chronic hepatitis C The research, published in The Lancet, is the first to demonstrate the clinical effectiveness of DAAs on the disease. It suggests that they should be considered